| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/03/2015 | US8969411 Vitamin C composition for use in the prevention and treatment of stretch other skin conditions and methods of using the same |
| 03/03/2015 | US8969410 Pharmaceutical composition for alleviating or treating gout and uses thereof |
| 03/03/2015 | US8969409 Treatment for pulmonary hypertension |
| 03/03/2015 | US8969408 Use of lignan-type compounds or extract of nutmeg or aril of nutmeg comprising the same |
| 03/03/2015 | US8969407 Administration of coumarin, butylated hydroxyanisole and ethoxyquine for the treatment of canities |
| 03/03/2015 | US8969406 Use of compound for inhibiting glutathione s-transferase omega 1 activity and method for synthesizing the same |
| 03/03/2015 | US8969405 Anticancer compounds and methods of making and using same |
| 03/03/2015 | US8969404 Purifying crude furan 2,5-dicarboxylic acid by hydrogenation |
| 03/03/2015 | US8969403 Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound |
| 03/03/2015 | US8969402 Combined acetylcholinesterase inhibitor and quaternary ammonium antimuscarinic therapy to alter progression of cognitive diseases |
| 03/03/2015 | US8969401 Sulfonylpyrroles |
| 03/03/2015 | US8969400 Pharmaceutical compositions of 5-hydroxytryptophan and serotonin-enhancing compound |
| 03/03/2015 | US8969398 Methods of treating hepatic encephalopathy |
| 03/03/2015 | US8969397 Systems and methods to treat pain locally |
| 03/03/2015 | US8969396 Method for treating a B-raf associated cancer with an Hsp90 inhibitor |
| 03/03/2015 | US8969395 Triterpenoid derivatives useful as antiproliferative agents |
| 03/03/2015 | US8969394 Thiophenecarboxamide derivatives as EP4 receptor ligands |
| 03/03/2015 | US8969392 Pesticide composition comprising propamocarb-fosetylate and an insecticidally active substance |
| 03/03/2015 | US8969391 Use quaternary pyridinium salts as vasoprotective agents |
| 03/03/2015 | US8969390 Composition containing sorbitan monocaprylate and antimicrobial substances |
| 03/03/2015 | US8969389 Substituted 6-methylnicotinamides as mGluR5 positive allosteric modulators |
| 03/03/2015 | US8969388 Substituted pyrazolone compounds and methods of use |
| 03/03/2015 | US8969387 Pyrrole compounds |
| 03/03/2015 | US8969386 Modulators of CFTR |
| 03/03/2015 | US8969385 Ocular formulations of norketotifen |
| 03/03/2015 | US8969384 Flavonoid compounds and process for preparation thereof |
| 03/03/2015 | US8969383 Picolinamide derivatives as TTX-S blockers |
| 03/03/2015 | US8969382 Modulators of cystic fibrosis transmembrane conductance regulator |
| 03/03/2015 | US8969381 Chemokine CXCR4 receptor modulators and used related thereto |
| 03/03/2015 | US8969379 Pharmaceutical compositions of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7=methoxy-6-quinolinecarboxide |
| 03/03/2015 | US8969378 Inhibitor of the differentiation of T cells into Th1 cells |
| 03/03/2015 | US8969377 Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
| 03/03/2015 | US8969376 Pyrazolopyrimidine compounds and their use as PDE10 inhibitors |
| 03/03/2015 | US8969375 CDK9 kinase inhibitors |
| 03/03/2015 | US8969374 Iso-ergoline derivatives |
| 03/03/2015 | US8969373 HCV protease inhibitors |
| 03/03/2015 | US8969372 Aryl imidazoles and their use as anti-cancer agents |
| 03/03/2015 | US8969371 Compositions and methods for weight loss in at risk patient populations |
| 03/03/2015 | US8969370 3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists |
| 03/03/2015 | US8969369 Abuse-resistant controlled-release opioid dosage form |
| 03/03/2015 | US8969368 Crystalline, anhydrous forms of oxymorphone hydrochloride |
| 03/03/2015 | US8969367 Crystalline forms of a 3-carboxypropyl-aminotetralin compound |
| 03/03/2015 | US8969366 Substituted pyrimidinylpyrrolopyridinone derivatives, process for their preparation and their use as kinase inhibitors |
| 03/03/2015 | US8969365 Thiopyrimidinecarboxamides as CXCR1/2 modulators |
| 03/03/2015 | US8969364 Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders |
| 03/03/2015 | US8969363 Heterocyclic compounds and uses thereof |
| 03/03/2015 | US8969362 9-substituted 8-oxoadenine compound |
| 03/03/2015 | US8969361 Cyclopropanecarboxylate esters of purine analogues |
| 03/03/2015 | US8969360 Compounds useful as inhibitors of ATR kinase |
| 03/03/2015 | US8969358 Buprenorphine analogs |
| 03/03/2015 | US8969357 Methods for treating HCV |
| 03/03/2015 | US8969356 Compounds useful as inhibitors of ATR kinase |
| 03/03/2015 | US8969355 1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1a activity for the treatment of cognitive impairment |
| 03/03/2015 | US8969354 Fatty acid fumarate derivatives and their uses |
| 03/03/2015 | US8969353 Aminoalcohol lipidoids and uses thereof |
| 03/03/2015 | US8969352 Substituted 2-azabicycles and their use as orexin receptor modulators |
| 03/03/2015 | US8969351 Crystalline form of an inhibitor of MDM2/4 and p53 interaction |
| 03/03/2015 | US8969350 Pharmaceutical product comprising a p38 kinase inhibitor and a second active ingredient |
| 03/03/2015 | US8969349 Substituted quinoxalines and quinoxalinones as PDE-10 inhibitors |
| 03/03/2015 | US8969348 Chymase inhibitors |
| 03/03/2015 | US8969347 Compounds and methods for treating inflammatory and fibrotic disorders |
| 03/03/2015 | US8969346 Amino-pyridazine skeletal muscle modulators |
| 03/03/2015 | US8969345 Dibenzooxepin derivative |
| 03/03/2015 | US8969344 Method for assay on the effect of vascularization inhibitor |
| 03/03/2015 | US8969343 Histone demethylase inhibitors |
| 03/03/2015 | US8969342 Compounds and methods for treating mammalian gastrointestinal microbial infections |
| 03/03/2015 | US8969341 Pyrazolopyrrolidine compounds |
| 03/03/2015 | US8969340 Methods for treating chronic pelvic pain syndrome |
| 03/03/2015 | US8969339 Compositions and methods for bone formation and modeling |
| 03/03/2015 | US8969338 Ethynyl derivatives |
| 03/03/2015 | US8969336 Diamino heterocyclic carboxamide compound |
| 03/03/2015 | US8969335 Benzonitrile derivatives as kinase inhibitors |
| 03/03/2015 | US8969334 Nitrogen containing compounds and their use |
| 03/03/2015 | US8969333 Therapeutic compositions and methods |
| 03/03/2015 | US8969332 Aryloxy dihalopropenyl ether compounds and uses thereof |
| 03/03/2015 | US8969331 Treatment of skin and mucosal superficial wounds using adrenergic receptor agonists |
| 03/03/2015 | US8969330 Steroids as agonists for FXR |
| 03/03/2015 | US8969329 Allopregnanolone in a method for enhancing neurological function |
| 03/03/2015 | US8969328 Progesterone receptor antagonists |
| 03/03/2015 | US8969327 Substituted androst-4-ene diones |
| 03/03/2015 | US8969326 Estrogen antagonists as treatments for sclerosing disorders |
| 03/03/2015 | US8969325 TRPV1 antagonists |
| 03/03/2015 | US8969324 Pharmaceutical composition comprising 11-deoxy-prostaglandin compound and method for stabilizing the compound |
| 03/03/2015 | US8969323 Priming solutions for cardiopulmonary bypass |
| 03/03/2015 | US8969322 Extracorporeal devices and methods of treating complications of pregnancy |
| 03/03/2015 | US8969321 Medical and nutritional applications of highly refined cellulose |
| 03/03/2015 | US8969320 Hyaluronic acid derivatives containing groups able to release NO |
| 03/03/2015 | US8969319 Agent for applying to mucosa and method for the production thereof |
| 03/03/2015 | US8969317 MicroRNA compounds and methods for modulating miR-21 activity |
| 03/03/2015 | US8969316 Compounds and methods for modulating expression of DGAT2 |
| 03/03/2015 | US8969315 Enhancement of placental stem cell potency using modulatory RNA molecules |
| 03/03/2015 | US8969313 Methods and compounds for preventing and treating a tumour |
| 03/03/2015 | US8969312 Low side effect pharmaceutical composition containing antituberculosis drugs |
| 03/03/2015 | US8969310 Potentiation of anticancer agents |
| 03/03/2015 | US8969308 Treatment of T-cell mediated diseases |
| 03/03/2015 | US8969303 Tocotrienol esters |
| 03/03/2015 | US8969297 Methods and compositions for the induction of hypothermia |
| 03/03/2015 | US8969292 High affinity leptins and leptin antagonists |
| 03/03/2015 | US8969282 Low odor, hard surface sporicide |
| 03/03/2015 | US8969080 Remedy for the treatment of cardio-vascular diseases or disorders |